Objective This study aimed to identify factors associated with the functional outcomes of patients with cerebral embolism due to nonvalvular atrial fibrillation. Methods We retrospectively investigated the short-term functional outcomes of 134 patients diagnosed with cardiogenic cerebral embolism due to nonvalvular atrial fibrillation during the period of May 2006 to August 2008. Functional state was evaluated using the modified Rankin Scale (mRS) on admission and at discharge. Results A good functional outcome (mRS !2) at discharge was significantly associated with low mRS on admission (OR: 0.07; CI: 0.03-0.18; p<0.001), and a low C-reactive protein (CRP) level (OR: 0.19; CI: 0.04-0.89; p<0.05).
Introduction
Atrial fibrillation (AF) is a common arrhythmia and a major risk factor for strokes (1) . It is also a predictive factor for severe stroke and early death in acute ischemic stroke (2) . In particular, nonvalvular atrial fibrillation (NVAF) has become recognized as a major factor leading to cardioembolic stroke as the number of elderly patients with NVAF has increased (3, 4) . Patients with cardioembolic stroke usually have larger infarcts on computed tomographic outcome. In addition, many other predictors have been reported to have a univariable relationship with outcome. However, their multivariable relationships are less clear because of conflicting results in the literature (9) (10) (11) (12) (13) . Therefore, we performed a retrospective study of consecutive patients with cardiogenic brain embolism due to NVAF and subsequently analyzed the predicting factors associated with short-term functional prognosis.
Subjects and Methods
Of 1,420 stroke patients admitted to the Nishinomiya Kyoritsu Neurosurgical Hospital between May 2006 and August 2008, we studied 134 patients who were diagnosed with cerebral embolism due to NVAF. Diagnosis of cardiogenic cerebral embolism was made on the basis of clinical examinations and laboratory findings such as CT, magnetic resonance imaging (MRI), MR angiography, electrocardiography (ECG), and echocardiogram. All patients showed the sudden onset of clinical symptoms with maximal focal neurologic deficits at the time of onset, or cortical infarct on CT or MRI. Patients with an ipsilateral common or internal carotid artery stenosis of more than 70% in the case of hemispheric ischemia, a stenosis of more than 50% of at least one vertebral artery, or another reasonable etiology (14) were excluded from this study.
Cardiovascular risk factors such as the presence or absence of hypertension, diabetes mellitus, dyslipidemia, AF, smoking, and previous stroke, were ascertained through interviews with patients conducted by neurosurgeons and neurologists. Hypertension was defined as systolic blood pressure "140 mmHg or diastolic blood pressure "90 mmHg, self-reported history of hypertension, or current use of antihypertensive medication. Diabetes mellitus was defined as fasting blood sugar "126 mg/dL, self-reported diabetes history, or use of insulin or oral hypoglycemic medication. Dyslipidemia was defined as total serum cholesterol >220 mg/dL, total serum triglyceride >150 mg/dL, self-reported history of dyslipidemia, or current lipid-lowering treatment.
Smoking was defined by current smoking or history of tobacco use at any time. AF was documented by current or past ECG. Most patients received single or combined therapy involving edaravone, heparin, or glycerol. However, patients with tissue-plasminogen activator (t-PA) therapy were not included. Physiotherapy intervention was performed for all patients as soon as possible.
Functional state was evaluated using the modified Rankin Scale (mRS) (15) , which is gaining importance as a means to quantify disability following a stroke. Patients were divided into two groups according to their functional state at discharge: those with good outcome (group A; mRS !2) and those with poor outcome (group B; mRS "3). Sixteen patients (11.9%) died during the admission and therefore received an mRS score of 6. Changes in patient condition during the admission period were also evaluated and divided into 3 groups: improved group (improved mRS "1 grade), unchanged group (changed mRS <1 grade), and worsened group (worsened mRS "1 grade).
Statistical Analysis
The initial univariate analysis compared clinical variables between patients with good functional state and those with poor functional state using the chi-square test for categorical data and the 2-sample t-test for continuous data. The nonparametric Wilcoxon rank sum test was applied to compare mRS of the good outcome group with that of the poor outcome group. Baseline factors were selected from clinically relevant variables that were reasonably available to physicians during acute hospitalization following stroke. These factors included demographics, medical history, laboratory results, and stroke-severity (evaluated by mRS), and were the only variables considered in building the model for predicting short-term outcomes. Although post-stroke therapy (physical, occupational, and speech) might also modify outcome, it was not included in the model because of its bidirectional effect, that is, patients with excellent or poor poststroke status were both unlikely to receive therapy.
To investigate the factors influencing functional outcome at discharge, a forward logistic regression analysis was performed using good outcome at discharge as the dependent variable. Variables significant at p<0.05 in the univariate analysis of baseline factors were analyzed as independent variables. We used similar methods to clarify the factors associated with functional changes that occurred during hospitalization. Univariate analysis was performed using one-way ANOVA or the Kruskal-Wallis test. For logistic regression analysis, improved functional change was used as the dependent variable.
Analysis was conducted using SPSS version 11.0 (SPSS Japan Inc.) and p<0.05 was considered significant. All values were expressed as mean ± standard deviations (SD) or as number (%).
Results
A total of 134 patients were evaluated. Fifty-five had a good outcome (group A, mRS !2), while 79 had a poor outcome (group B, mRS "3). Table 1 shows the clinical characteristics of enrolled patients by functional state at discharge. Group A showed a significantly higher male rate (p< 0.001), younger age (p<0.001), lower mRS on admission (p <0.001), and higher prevalence of dyslipidemia (p<0.05) and statin use (p<0.01) than group B. No significant differences were found in the presence of prior stroke, warfarin or antiplatelet therapy, smoking, or diabetes mellitus. Moreover, mRS on admission was significantly correlated with mRS at discharge; however, there was no significant difference in time to hospitalization.
In addition, there were significant differences in systolic blood pressure (p<0.001), C-reactive protein (CRP) level (p< 0.01), blood sugar (p<0.05), and the presence of proteinemia (Table 3 ). There were significant differences in age (p<0.01), the presence of hypertension (p<0.005), presence of dyslipidemia (p<0.01), and rate of statin use (p<0.01). Significant differences in mRS were also found on admission (p<0.01), as well as in systolic (p< 0.01) and diastolic (p<0.01) pressure, blood sugar (p<0.05), presence of proteinuria (p<0.05), and heparin (p<0.01) among the 3 groups. Multivariate logistic regression analysis was performed for the change of functional outcome and showed that the independent predictive variable for functional improvement was the presence of dyslipidemia (OR: 2.74; CI: 1.11-6.76; p<0.05), whereas higher diastolic blood pressure on admission (OR: 0.95; CI: 0.90-0.99; p<0.05) (Table 4 ).
Discussion
The prognosis of cardioembolic stroke has been assessed less favorably than atherothrombolic stroke outcome, in particular due to the high mortality rates. Relatively high mortality rates (about 18%) have been reported in patients with NVAF (14) , although the early mortality rate was about 12% in the present study.
The findings regarding prognostic factors remain inconsistent. The reasons for this may be due to the chosen analytical method as some studies used functional status on discharge as the outcome measure while others used improvement in functional status. Here, we analyzed the factors influencing the prognosis using both outcome measures.
Univariate analysis revealed that the group with males, younger age, presence of dyslipidemia, pretreatment of statin, low mRS on admission, low systolic and diastolic blood pressure, low CRP level, low blood sugar, absence of proteinuria, and treatment with heparin and glycerol, showed a good functional outcome. Furthermore, multivariate analysis showed that significant prognostic factors of good outcome at discharge were only mRS on admission and CRP level.
Our results demonstrated the importance of determining initial severity for the functional prognosis. Aburto-Murrieta et al (16) investigated the predictors of good and poor prognoses following a complete stroke secondary to an NVAF and found that a Rankin score !3 on admission suggested a poor prognosis. Furthermore, DeGraba et al (10) suggested that early clinical course of the neurological deficit following acute stroke is dependent on the initial stroke severity.
In the present study, serum CRP level was also a determinant of functional outcome in patients with cardiogenic embolism due to NVAF. Inflammation, mediated by factors such as high-sensitivity CRP (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), has also been reported as an independent risk factor of atherothrombotic stroke (17) . Moreover, experimental studies have revealed that inflammation in ischemia lesions can affect the expansion of such lesions (18). Elkind et al (19) showed that the level of hs-CRP increases with stroke severity and may be associated with mortality to a greater degree than recurrence. The present results suggest that factors contributing to inflammation, such as CRP, increase with stroke severity and are associated with the prognosis following ischemic attack.
Here, functional improvement was significantly associated with presence of dyslipidemia, low diastolic blood pressure, and low blood sugar on admission.
In contrast to previous studies, functional improvement was not significantly influenced by the mRS on admission. Baird et al (20) reported that the High National Institutes of Health Stroke Scale (NIHSS) score was associated with decreased stroke recovery. On the other hand, Jongbloed (13) reported that the functional score on admission was a strong predictor of discharge functional status, but its relationship with improved function remains unclear. Similarly, variables predicting improvement in functional status may differ from variables predicting functional status at discharge (21) (22) (23) .
In the present study, the presence of dislipidemia was positively associated with functional improvement. This result is not in accordance with previous reports (24) because conditions such as hypertension and dyslipidemia have been shown to have a negative correlation with functional outcome and functional gain in patients following stroke. High cholesterol levels, on the other hand, have been associated with lower mortality rate in acute ischemic stroke (25, 26) . In addition, Ogushi et al (27) reported that mRS at discharge was significantly lower in patients with hyperlipidemia than in those without hyperlipidemia. The reason for this finding was explained by the idea that the Japanese criteria for determining hyperlipidemia are very low (LDL: 140 mg/dL; triglyceride: 150 mg/dL). Therefore, there is a high possibility that false-positives may indicate hyperlipidemia. Another explanation for our result is that statin usage was more frequent prior to stroke in group A than in group B. Statin pretreatment, however, was not a significant factor in the multivariate analysis.
The benefit of statin treatment for primary and secondary ischemic stroke prevention has been proven in a number of studies (28, 29) , and several studies have shown that patients pretreated with statins had favorable outcomes following ischemic stroke with (30) and without thrombolytic treatment (31) (32) (33) . Statins have many beneficial pleiotropic effects including antioxidant properties, immunomodulatory actions, improving endothelial function, increasing nitric oxide bioavailability, promoting atherosclerotic plague stabilization, and inhibiting inflammatory response, all of which could provide additional benefits for cerebroprotection and stroke recovery, as well as in cases of cardioembolic strokes. Moreover, prestroke statin use enhances collateralization in acute strokes. This collateralization effect could be prevented by inducing angiogenesis and aids in recovery following an arterial occlusion (34) . Here, the association between dyslipidemia and functional recovery could be due in part to statin pretreatment. However, further study is necessary to verify this explanation, since the difference in the number of patients who received pretreatment between the improved group (12/70) and the worsened group (0/20) was small (only 12).
Fujishima et al (35) reported that an early prognosis for neurological deficits in the first 2 months following the onset of stroke was poorer in the hypertension group than in the normotensive group. Other authors (14) reported that hypertension was a risk for poor outcome in patients with cardiogenic brain embolism. Here, the presence of hypertension before admission was not associated with functional improvement. Conversely, low diastolic blood pressure on admission was a determinant of functional improvement. Nonsustained elevation of blood pressure on admission was not considered as evidence of hypertensive vascular disease since blood pressure may rise with the stress of acute stroke (36) . Although high blood pressure on admission indicated a strong association with a poor prognosis in ischemic stroke (37) (38) (39) , the mechanisms involved remain unclear. However, it has been proposed that an increased blood pressure may contribute to the risk of hemorrhagic transformation or cerebral edema. Such a finding could be explained if the association between high blood pressure and poor stroke outcome was indeed mediated by inflammatory response. Acute hypertension may stimulate inflammation in patients with acute stroke (40) , and such inflammation may subsequently intervene in the development of high blood pressure via a reaction in nitric oxide and changes in the renin-angiotensin system (41, 42) . Systemic inflammation has also been associated with a poor prognosis in ischemic stroke (43, 44) .
Hyperglycemia may worsen brain injury during acute cerebral infarction and may be associated with adverse outcomes (45) . In some experimental stroke models, hyperglycemia increases reperfusion injury and infarct-related hemorrhage (46) . It has also been shown to increase infarct volume in some human studies (47) . Kaarisalo et al (48) reported that diabetes was associated with a higher risk of death and disability for up to 4 weeks following the onset of stroke. On the other hand, Woo et al (49) measured fasting blood glucose, glycosylated hemoglobin, and fructosamine concentration in 304 consecutive patients admitted with acute stroke, and those with stress hyperglycemia but not diabetes had increased mortality. Despite having glucose concentrations similar to those with stress hyperglycemia, diabetes patients did not have a worse outcome compared with those without diabetes. Woo et al subsequently concluded that the association between glucose concentration and outcome is a reflection of stress relating to stroke severity, rather than a direct harmful effect of glucose on damaged neurons. Similarly, during an analysis of 477 brain infarcts, Mazighi et al (50) found that elevated glucose levels on admission were associated with poor outcomes and higher post-stroke mortality. In addition, Gray et al (51) also reported an increase in mortality at 4 weeks in patients with elevated blood glucose irrespective of their glycosylated hemoglobin (HbA1c) value.
In the present study, no relationship was found between pretreatment of warfarin and functional state, although Ay et al (52) suggest that preadmission warfarin use was associated with a therapeutic level (INR !2) of anticoagulation and can offer the benefit of limiting the extent of ischemic injury in the event of acute stroke. The discrepancy between these results may be related to the fact that warfarin was not properly administered in most cases in the present study.
Here, we evaluated the severity of stroke on admission using mRS, as the means for determining functional state. The evaluation of stroke severity by mRS, however, might be difficult in cases with disturbance of consciousness or in those undergoing treatment in the acute stage. As stroke severity should generally be evaluated using the NIHSS or Japan Stroke Scale (JSS) (53), further study using such measures is needed.
In summary, the functional state at discharge was associated with both the functional state on admission and the serum CRP level. On the other hand, functional improvement was related to presence of dyslipidemia, low diastolic blood pressure, and low blood sugar on admission. The present study suggests that functional state on admission is a strong predictor of functional state at discharge, but functional state on admission may not be associated with improvement in function.
